DE69713335D1 - Polymere zur abgabe von stickstoffoxide in vivo - Google Patents

Polymere zur abgabe von stickstoffoxide in vivo

Info

Publication number
DE69713335D1
DE69713335D1 DE69713335T DE69713335T DE69713335D1 DE 69713335 D1 DE69713335 D1 DE 69713335D1 DE 69713335 T DE69713335 T DE 69713335T DE 69713335 T DE69713335 T DE 69713335T DE 69713335 D1 DE69713335 D1 DE 69713335D1
Authority
DE
Germany
Prior art keywords
polymer
polymers
vivo
delivery
nitrogen oxides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69713335T
Other languages
English (en)
Other versions
DE69713335T2 (de
Inventor
S Stamler
J Toone
S Stack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University Medical Center
Original Assignee
Duke University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University Medical Center filed Critical Duke University Medical Center
Application granted granted Critical
Publication of DE69713335D1 publication Critical patent/DE69713335D1/de
Publication of DE69713335T2 publication Critical patent/DE69713335T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
DE69713335T 1996-08-02 1997-07-28 Polymere zur abgabe von stickstoffoxide in vivo Expired - Lifetime DE69713335T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/691,862 US5770645A (en) 1996-08-02 1996-08-02 Polymers for delivering nitric oxide in vivo
PCT/US1997/013475 WO1998005689A1 (en) 1996-08-02 1997-07-28 Polymers for delivering nitric oxide in vivo

Publications (2)

Publication Number Publication Date
DE69713335D1 true DE69713335D1 (de) 2002-07-18
DE69713335T2 DE69713335T2 (de) 2003-02-13

Family

ID=24778280

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69713335T Expired - Lifetime DE69713335T2 (de) 1996-08-02 1997-07-28 Polymere zur abgabe von stickstoffoxide in vivo

Country Status (10)

Country Link
US (1) US5770645A (de)
EP (1) EP0914348B1 (de)
JP (1) JP4312263B2 (de)
KR (1) KR20000029774A (de)
AT (1) ATE219108T1 (de)
AU (1) AU714972B2 (de)
CA (1) CA2262922C (de)
DE (1) DE69713335T2 (de)
NZ (1) NZ334221A (de)
WO (1) WO1998005689A1 (de)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232434B1 (en) * 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
JP4856295B2 (ja) * 1997-07-03 2012-01-18 アメリカ合衆国政府 新規な一酸化窒素放出アミジン誘導ジアゼニウムジオレート及びその組成物
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
DE69942486D1 (de) 1998-01-15 2010-07-22 Cornell Res Foundation Inc Grabenisolation für mikromechanische bauelemente
CN1306444A (zh) * 1998-06-19 2001-08-01 奥西比奥公司 具有抗感染和避孕性能的医学装置
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
US6299980B1 (en) 1998-09-29 2001-10-09 Medtronic Ave, Inc. One step lubricious coating
US20040043068A1 (en) * 1998-09-29 2004-03-04 Eugene Tedeschi Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6379691B1 (en) 1998-09-29 2002-04-30 Medtronic/Ave, Inc. Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6838050B1 (en) 1999-06-04 2005-01-04 Oxibio, Inc. Methods and devices for providing anti-infective activity to a medical device
US7045152B2 (en) 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
US6314956B1 (en) 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
DE19945484A1 (de) * 1999-09-22 2001-04-05 Kolb Bachofen Victoria NO-freisetzende topisch applizierbare Zusammensetzung
US6737447B1 (en) * 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US6613432B2 (en) * 1999-12-22 2003-09-02 Biosurface Engineering Technologies, Inc. Plasma-deposited coatings, devices and methods
IL151604A0 (en) * 2000-03-20 2003-04-10 Novovascular Inc Matrices containing nitric oxide donors and reducing agents
US6270779B1 (en) 2000-05-10 2001-08-07 United States Of America Nitric oxide-releasing metallic medical devices
US6417347B1 (en) * 2000-08-24 2002-07-09 Scimed Life Systems, Inc. High yield S-nitrosylation process
US6410622B1 (en) * 2000-09-11 2002-06-25 Gregory W. Endres Method of preventing fouling organisms in marine environments and polymer-bound nitric oxide/nitric oxide-releasing compositions usable therefor
US7049308B2 (en) * 2000-10-26 2006-05-23 Duke University C-nitroso compounds and use thereof
US6780849B2 (en) * 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US6398806B1 (en) * 2000-12-26 2002-06-04 Scimed Life Systems, Inc. Monolayer modification to gold coated stents to reduce adsorption of protein
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
DE10112825A1 (de) * 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE60202677T2 (de) * 2001-05-25 2005-12-29 Medtronic, Inc., Minneapolis Implantierbare medizinische vorrichtung mit kontrollierter freigabe von gasförmigen mitteln
US6656216B1 (en) * 2001-06-29 2003-12-02 Advanced Cardiovascular Systems, Inc. Composite stent with regioselective material
US7135189B2 (en) * 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
EP1436018A1 (de) * 2001-09-26 2004-07-14 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Stickoxid freisetzende beschichtete medizinprodukte und verfahren zu ihrer herstellung
US6703046B2 (en) 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
ATE450187T1 (de) * 2001-12-06 2009-12-15 Univ Duke Verhinderung von hautlappennekrose in der plastischen chirurgie
AU2006252204B2 (en) * 2001-12-06 2010-07-08 Duke University Prevention of Flap Necrosis in Plastic Surgery
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
WO2003092763A1 (en) * 2002-05-03 2003-11-13 Duke University Carbon nanotubules for storage of nitric oxide
US6949530B2 (en) * 2002-07-18 2005-09-27 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
PT2277551E (pt) 2002-09-06 2013-08-22 Cerulean Pharma Inc Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
PL217085B1 (pl) * 2002-09-11 2014-06-30 Fresenius Kabi Gmbh Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania koniugatu hydroksyalkiloskrobi i polipeptydu, zastosowanie koniugatu hydroksyalkiloskrobi i polipeptydu oraz kompozycja farmaceutyczna koniugatu hydroksyalkiloskrobi i polipeptydu
US20030039697A1 (en) * 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
FR2845090B1 (fr) * 2002-10-01 2004-12-24 Merck Sante Sas Nouveau polymere de nitrosation en synthese organique
US20040098106A1 (en) * 2002-11-14 2004-05-20 Williams Michael S. Intraluminal prostheses and carbon dioxide-assisted methods of impregnating same with pharmacological agents
US7285287B2 (en) * 2002-11-14 2007-10-23 Synecor, Llc Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses
US6932930B2 (en) * 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
FR2852959B1 (fr) 2003-03-28 2008-02-15 Centre Nat Rech Scient Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives
WO2005004884A2 (en) 2003-07-09 2005-01-20 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
BRPI0413450A (pt) * 2003-08-08 2006-10-17 Fresenius Kabi De Gmbh conjugados de hidroxialquil amido e g-csf
US8017074B2 (en) 2004-01-07 2011-09-13 Noxilizer, Inc. Sterilization system and device
CA2552735C (en) 2004-01-07 2012-09-11 Noxilizer, Inc. Sterilization system and device
EP1737502B1 (de) * 2004-01-22 2014-01-15 The University of Akron Polymer-no-donor-prädrug-nanofaser-beschichtung für medizinprodukte
CA2555552A1 (en) * 2004-02-09 2005-09-09 Noxilizer, Inc. Nitric oxide-releasing molecules
CN102302787A (zh) * 2004-03-11 2012-01-04 费森尤斯卡比德国有限公司 羟烷基淀粉和蛋白质的接合物
CA2558738C (en) 2004-03-11 2013-02-05 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
US8110259B2 (en) 2004-04-02 2012-02-07 Curwood, Inc. Packaging articles, films and methods that promote or preserve the desirable color of meat
US8470417B2 (en) 2004-04-02 2013-06-25 Curwood, Inc. Packaging inserts with myoglobin blooming agents, packages and methods for packaging
US8029893B2 (en) 2004-04-02 2011-10-04 Curwood, Inc. Myoglobin blooming agent, films, packages and methods for packaging
US8545950B2 (en) 2004-04-02 2013-10-01 Curwood, Inc. Method for distributing a myoglobin-containing food product
US7867531B2 (en) 2005-04-04 2011-01-11 Curwood, Inc. Myoglobin blooming agent containing shrink films, packages and methods for packaging
US8741402B2 (en) 2004-04-02 2014-06-03 Curwood, Inc. Webs with synergists that promote or preserve the desirable color of meat
US8053047B2 (en) 2004-04-02 2011-11-08 Curwood, Inc. Packaging method that causes and maintains the preferred red color of fresh meat
EP1750782A1 (de) * 2004-04-29 2007-02-14 Cube Medical A/S Ballon zur verwendung bei der angioplastie mit einer aussenschicht aus nanofasern
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20060052822A1 (en) * 2004-08-31 2006-03-09 Mirizzi Michael S Apparatus and material composition for permanent occlusion of a hollow anatomical structure
US7972354B2 (en) 2005-01-25 2011-07-05 Tyco Healthcare Group Lp Method and apparatus for impeding migration of an implanted occlusive structure
US20070014734A1 (en) 2005-01-31 2007-01-18 O'donnell John P Glucuronidated nebivolol metabolites
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
WO2006084913A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
WO2006084914A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Device for gastric treatment and manufacturing process for the same
EP1757278A1 (de) 2005-08-23 2007-02-28 NOLabs AB Vorrichtung, System und Methode enthaltend eine verkapselte Flüssigkeit zur Stickstoffmonoxyd-Freisetzung von einem Polymer
DK1846058T3 (da) 2005-02-11 2009-11-23 Nolabs Ab Indretning, fremgangsmåde og anvendelse til behandling af neuropati med nitrogenoxid
EP1690557A1 (de) * 2005-02-11 2006-08-16 NOLabs AB Vorrichtung zur Behandlung von rektalen Krankheiten und deren Herstellungsprozess
EP1700611A1 (de) * 2005-02-11 2006-09-13 NOLabs AB Vorrichtung zur Behandlung von Krankheiten der Mundhöhle und deren Herstellungsprozess
EP1846009A2 (de) * 2005-02-11 2007-10-24 NOLabs AB Verbesserte vorrichtung zur anwendung von medikamenten, herstellungsverfahren dafür und behandlungsverfahren
PL1861130T3 (pl) * 2005-02-11 2009-02-27 Nolabs Ab Urządzenie i sposób leczenia grzybicy skóry, a w szczególności grzybicy paznokci
EP1690532A1 (de) * 2005-02-11 2006-08-16 NOLabs AB Vorrichtung zur Behandlung vom Magen und ihr Verfahren zur Herstellung
WO2006096572A1 (en) * 2005-03-04 2006-09-14 The University Of Akron Ethambutol based nitric oxide donors
EP1861124A2 (de) * 2005-03-11 2007-12-05 Fresenius Kabi Deutschland GmbH Herstellung von bioaktiven glykoproteinen aus inaktiven ausgangsmaterialien durch konjugation mit hydroxyalkylstärke
WO2006100154A1 (en) 2005-03-24 2006-09-28 Nolabs Ab Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
EP1704876A1 (de) * 2005-03-24 2006-09-27 NOLabs AB Kosmetische Behandlung, Vorrichtung zur Durchführung dieser Behandlung und deren Herstellungsmethode
US20090039565A1 (en) * 2005-04-21 2009-02-12 The University Of Akron Process for producing fibers and their uses
CA2606565C (en) 2005-05-27 2016-05-10 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
EP1731176A1 (de) 2005-06-01 2006-12-13 NOLabs AB Vorrichtung zur Vorbehandlung beinhaltend Stickstoffmonoxid
EP1728438A1 (de) 2005-06-01 2006-12-06 NOLabs AB Futtermittel
EP1764119A1 (de) * 2005-09-09 2007-03-21 NOLabs AB Implantate mit verbesserter Osteointegration
EP1762250A1 (de) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Konjugate welche durch chemische Ligation zwischen Hydroxyalkylstärken und aktiven Substanzen mit Bildung eines Thiazolidin-Ringes entstehen
US20090010989A1 (en) * 2005-09-12 2009-01-08 N0Labs Ab Coating For Implants and Implants With Improved Osteointegration, and Manufacturing Method
EP1790335A1 (de) * 2005-11-14 2007-05-30 NOLabs AB Zusammensetzung und deren Verwendung für die Herstellung eines Medikamentes zur Behandlung, prophylaktischen Behandlung und Verhinderung von Krebs und/oder von Infektionskrankheiten in den Harnwegen
WO2007059311A2 (en) * 2005-11-16 2007-05-24 Nitromed, Inc. Furoxan compounds, compositions and methods of use
JP2009518516A (ja) * 2005-12-06 2009-05-07 アミュレット ファーマシューティカルズ インコーポレイティッド 一酸化窒素放出ポリマー
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US7993560B2 (en) * 2006-04-20 2011-08-09 Curwood, Inc. Process for introducing an additive into a polymer melt
EP2015841A4 (de) * 2006-04-27 2010-06-23 St Jude Medical Implantierbares medizinprodukt mit freisetzender verbindung
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
BRPI0721507A2 (pt) * 2007-03-27 2013-01-08 Nolabs Ab dispositivo de dispensaÇço de àxido nÍtrico tàpico, kit, uso de àxido nÍtrico, e, mÉtodos de dispensaÇço tàpica de àxido nÍtrico e de tratamento
ITMI20071341A1 (it) 2007-07-05 2009-01-06 Fidia Farmaceutici Derivati di acido ialuronico contenenti gruppi in grado di rilasciare no
CA2599082A1 (en) * 2007-08-27 2009-02-27 Ping I. Lee Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
WO2009065142A2 (en) 2007-11-15 2009-05-22 Biomedical Research Foundation Of Northwest Louisiana Use of nitrite salts in chronic ischemia
EP2070950A1 (de) * 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkylstärkederivate und deren Herstellungsverfahren
EP2070951A1 (de) * 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Verfahren zur Herstellung eines Hydroxyalkylstärkederivats mit zwei Linkern
AU2008345034A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US20090171455A1 (en) * 2007-12-31 2009-07-02 Boston Scientific Scimed, Inc. Biodegradable polymers
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
AU2010215774B2 (en) 2009-02-23 2015-05-21 Noxilizer, Inc. Device and method for gas sterilization
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
CN102695528B (zh) 2009-08-21 2016-07-13 诺万公司 创伤敷料、其使用方法及其形成方法
IN2012DN03428A (de) 2009-10-14 2015-10-23 Theravasc Inc
EP2591009A1 (de) 2010-07-09 2013-05-15 Fresenius Kabi Deutschland GmbH Stickoxidfreisetzende hydroxyalkylstärkederivate
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
ES2797649T3 (es) 2011-07-12 2020-12-03 Icu Medical Inc Dispositivo para entrega de agente antimicrobiano en un catéter transdérmico
US20130046375A1 (en) 2011-08-17 2013-02-21 Meng Chen Plasma modified medical devices and methods
IN2014KN03064A (de) * 2012-08-09 2015-05-08 Deepgreen Engineering Pte Ltd
CN104755505B (zh) 2012-08-17 2017-03-01 北卡罗来纳大学查珀尔希尔分校 水溶性的释放一氧化氮的聚葡糖胺和其用途
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
KR102472588B1 (ko) 2013-02-20 2022-12-01 보드 오브 슈퍼바이저스 오브 루이지애나 스테이트 유니버시티 앤드 애그리컬추얼 앤드 메카니컬 컬리지 니트라이트의 약제학적 제형 및 이의 용도
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
BR112016002387B1 (pt) 2013-08-08 2019-05-21 Novan, Inc. Composições farmacêuticas tópicas, e método para seu armazenamento
CA2919733A1 (en) 2014-08-08 2016-02-08 Novan, Inc. Topical compositions and methods of using the same
EP3294404A4 (de) 2015-05-08 2018-11-14 ICU Medical, Inc. Für die aufnahme von emittern von therapeutika konfigurierte medizinische verbinder
EP3423100A4 (de) 2016-03-02 2019-10-16 Novan, Inc. Zusammensetzungen zur behandlung von entzündungen und verfahren zur behandlung davon
CN109310630A (zh) 2016-04-13 2019-02-05 诺万公司 用于治疗感染的组合物、系统、试剂盒和方法
US11186681B2 (en) 2016-10-07 2021-11-30 The University Of North Carolina At Chapel Hill S-Nitrosothiol-mediated hyperbranched polyesters
PL3525865T3 (pl) 2016-10-14 2023-02-06 Icu Medical, Inc. Nasadki dezynfekcyjne dla łączników medycznych
CN110198959B (zh) 2017-01-03 2023-03-28 北卡罗米纳大学查佩尔希尔分校 释放一氧化氮的海藻酸盐作为可生物降解抗菌支架和相关方法
AU2018247167A1 (en) 2017-03-28 2019-09-26 The University Of North Carolina At Chapel Hill Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
JP2021515083A (ja) * 2018-03-06 2021-06-17 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ 生分解性の抗菌性足場としての一酸化窒素放出性シクロデキストリンおよびそれに関する方法
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
WO2020106985A1 (en) 2018-11-21 2020-05-28 Pursuit Vascular, Inc. Antimicrobial device comprising a cap with ring and insert
JP2022516461A (ja) * 2018-12-28 2022-02-28 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法
CA3204371A1 (en) 2020-12-07 2022-06-16 Icu Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138535A (en) * 1970-05-25 1979-02-06 Schweiger Richard Georg Nitrite esters of polyhydroxy polymers
DE69008454T2 (de) * 1989-08-07 1994-08-25 Takeda Chemical Industries Ltd Nitrolsothiolderivate, ihre Herstellung und Verwendung.
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
US5114506A (en) * 1991-07-08 1992-05-19 The United States Of America As Represented By The Secretary Of The Navy Energetic composites of cyclodextrin nitrate esters and nitrate ester plasticizers
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5632981A (en) * 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
CA2106105C (en) * 1993-09-14 2008-03-18 Larry K. Keefer Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
EP0724436B1 (de) * 1993-09-17 2004-01-07 Brigham And Women's Hospital Verwendung von stickoxid-addukten zur verhütung von thrombosen auf artifiziellen und vaskulären oberflächen
US5482925A (en) * 1994-03-17 1996-01-09 Comedicus Incorporated Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
US5583101A (en) * 1994-07-15 1996-12-10 Harvard College Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
US5700830A (en) * 1994-11-22 1997-12-23 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents for reducing metastasis risk
GB9423868D0 (en) * 1994-11-25 1995-01-11 Wellcome Found Compounds for use in medicine
GB9424694D0 (en) * 1994-12-07 1995-02-01 Wellcome Found Compounds for use in medicine

Also Published As

Publication number Publication date
JP4312263B2 (ja) 2009-08-12
KR20000029774A (ko) 2000-05-25
CA2262922A1 (en) 1998-02-12
CA2262922C (en) 2007-06-05
DE69713335T2 (de) 2003-02-13
AU714972B2 (en) 2000-01-13
EP0914348B1 (de) 2002-06-12
AU3967797A (en) 1998-02-25
US5770645A (en) 1998-06-23
NZ334221A (en) 1999-11-29
ATE219108T1 (de) 2002-06-15
JP2001524991A (ja) 2001-12-04
WO1998005689A1 (en) 1998-02-12
EP0914348A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
DE69713335D1 (de) Polymere zur abgabe von stickstoffoxide in vivo
BR9911754A (pt) Copolìmero linear de ciclodextrina, composição terapêutica, composição de ciclodextrina, processos de preparo de um copolìmero linear de ciclodextrina, e de um copolìmero linear de ciclodextrina oxidada, processo para produzir um polìmero reticulado de ciclodextrina, e, processo de tratamento
ATE237372T1 (de) Medizinische vorrichtung beschichtet mit stickstoffmonoxid modifizierte lineare polyethyleniminfasern und verfahren zu dessen herstellung
ES2117825T3 (es) Geles formados por la interaccion de polivinilpirrolidona con derivados de quitosano.
ATE253352T1 (de) Verwendung einer zusammensetzung enthaltend polyether block copolymere
TR200101751T2 (tr) Poliol-IFN-beta konjugatları
ATE225375T1 (de) Oberflächenmodifizierte endgruppen für biomedizinische polymere
DK0866816T3 (da) Lineær blokpolymer indeholdende urea- og urethangrupper, fremgangsmåde til fremstilling af lineære blokpolymerer samt anvendelse af blokpolymererne som implantater
DE69823055D1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
EP1568772A3 (de) Varianten des menschlichen Wachstumshormons
GB2288736B (en) Polymers carrying free radical groups and precursors thereof for wound dressing
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
GEP20074095B (en) Analogs of human insulin modified at position 29 of the b chain thereof
BR9508031A (pt) Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto
NZ515964A (en) A method for the prophylaxis and/or treatment of medical disorders
NO307656B1 (no) Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider
FI955424A (fi) Syklodekstriinien kanssa muodostettuja taksoli- ja taksoteeri- tai Taxus-uuteinkluusiokomplekseja ja niiden valmistus ja käyttö
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
DE59608422D1 (de) Verfahren zur Herstellung von Poly(diorganosiloxanen), Mischungen, enthaltend diese Poly(diorganosiloxane) und deren Verwendung
NZ508505A (en) Treatment of wounds using an Egr-1 transcription factor polypeptide
AU9731198A (en) Histogranin peptide and their analgesic use
BR9509354A (pt) Composição catalítica para a redução das emissões dos óxidos de nitrogénio no tratamento de um gás com teor elavado de oxigénio sistema catalitico processo de tratamento de gases com um teor elevado de oxigénio para a redução da emissões dos óxidos de nitrogénio e utilização da composição ou do sistema catalitico
CA2138793A1 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
TR199700842T1 (xx) �nsan DNase I Varyantlar�.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition